Home/ Supplements/ Vitamin K/ Quantum Bone Support

Quantum Bone Support

product on market Capsule Quantum Nutrition Labs Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 25% of ingredients have research evidence
B Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Vitamin K2 and calcium are supported by strong evidence for maintaining bone density and mineralization. The botanical and mineral support blends have limited clinical data available to verify their specific efficacy. Overall, the formula utilizes recognized nutrients for skeletal health.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Quantum Bone Support
Open Full PDF View on NIH DSLD →
Details

Label Data

3 Capsule(s)
Serving Size
30
Servings
Botanical with Nutrients
Product Type
25%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

114 mcg (95% DV)
Within RDA (1.0× RDA) 275 studies (A:9, B:175)
Calcium
84 mg (6% DV)
Nutra-Bone Mineral Support
690 mg
Advanced Botanical Bone Support
528 mg

Other Ingredients

Cellulose Water Silicon Dioxide
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested Use. Take 3 capsules daily.

QNL's Quality Program. Manufactured to avoid: added magnesium stearate (an undesirable excipient), artificial colors, artificial flavors or artificial preservatives.

Warnings & Precautions

California Residents Only Prop 65 Warning Reproductive Harm www.P65Warnings.ca.gov

Use only if seal is intact.

Consult your health practitioner if you are pregnant or nursing, taking medication or have a medical condition, before taking this product.

Formulation Notes

Healthy bone and connective tissue support with plant-based minerals, vitamin K2 and delta tocotrienol.

Healthy bone and connective tissue support with plant-based minerals, vitamin K2 and delta tocotrienol.

With Vitamin K2 Alfalfa

Plant-based support for healthy bones

Non GMO No added magnesium stearate

Plant based

Purity verified

Phytoforensic tested for adulterants

Additional Information

Store in a cool, dry place.

Scan to Discover More

Keep out of reach of children.

Metadata

Product Details

UPC / SKU8 07735 12367 3
DSLD Entry Date2024-01-24
Product TypeBotanical with Nutrients
FormCapsule
DSLD ID302306
Data Updated2026-04-11
Research

Research Evidence

332
Research Sources
59
Avg Quality
220
Meta Analysis
56
Systematic Review
30
Rct
16
Clinical Trial
3
Guideline
3
Regulatory Source
1
Narrative Review
1
Other
1
Openfda Safety
A Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Antiplatelet agents and anticoagulants for hypertension
Systematic Review The Cochrane database of systematic reviews 2022 PubMed DOI
A Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
A Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
View all evidence for Vitamin K →
Compare

Similar Products

View all Vitamin K products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.